{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-003828","form_type":"8-K","ticker":"HLYK","cik":"0001680139","company_name":"HealthLynked Corp","filed_at":"2025-01-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.417939+00:00","generated_at":"2026-05-28T01:11:56.071060+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"HealthLynked appoints Jeremy Daniel as part-time CFO; David Rosal resigns","bullets":["Jeremy Daniel appointed CFO effective Jan 15, 2025; replaces David Rosal who resigned without disagreement.","Daniel works two days per week at $66K annual salary; also serves as CFO of Innoveren Scientific since 2019.","Daniel previously CFO at Regenerative Medicine Solutions (2013-19) and controller at Omnicare (2012-14).","Daniel holds MBA from Xavier University, BBA in Accounting from University of Cincinnati, and is a CPA.","CEO Michael Dent cited Daniel's experience in financial operations and strategic planning as key to appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-003828","json":"https://secwatch.observer/filing/0001213900-25-003828.json","markdown":"https://secwatch.observer/filing/0001213900-25-003828.md","text":"https://secwatch.observer/filing/0001213900-25-003828.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1680139/000121390025003828/0001213900-25-003828-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1680139/000121390025003828/ea0227787-8k_health.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T01:11:56.071060+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"13c45bc1e3","claim":"Jeremy Daniel was appointed as Chief Financial Officer at HealthLynked Corp.","evidence_excerpt":"Effective January 15, 2025, HealthLynked Corp., a Nevada corporation (the “ Company ”), appointed Jeremy Daniel, age 48, as its part-time Chief Financial Officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1680139/000121390025003828/0001213900-25-003828-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"d85cadaf2c","claim":"David Rosal resigned as Chief Financial Officer at HealthLynked Corp.","evidence_excerpt":"Effective January 15, 2025, David Rosal tendered his resignation as Chief Financial Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1680139/000121390025003828/0001213900-25-003828-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}